Studies of FYN in prostate cancer have not been entirely consistent, with some studies suggesting that FYN is proliferative and metastatic in prostate cancer, while others suggest that FYN expression is downregulated in prostate cancer and is a tumor suppressor in prostate cancer. Here, FYN is linked to neoplasm.